WHO Target Product Profile for Lassa virus Vaccine

Overview

Purpose of the document:

Selected disease areas are identified as WHO priorities for product development. In the case of Lassa virus, target product profile development followed prioritization of Lassa fever as part of the WHO R&D Blueprint for Action to Prevent Epidemics. The target audience includes vaccine scientists, product developers, manufacturers and funding agencies.